Moderna and Merck Break Cancer Vaccine Barrier After Century-Long Struggle
Moderna and Merck have achieved a breakthrough in cancer vaccine research after a century of failures. The companies announced their success on August 13, 2026, with Moderna CEO Stephane Bancel celebrating at a Lebanese restaurant when he received the news.
Bancel was attending his friend's birthday party when he got the call. This achievement is significant as it marks a major milestone in cancer vaccine research, which has been ongoing for over a century without any success.
The breakthrough comes from the collaboration between Moderna and Merck, two pharmaceutical giants that have combined their expertise to develop an mRNA-based cancer vaccine. The vaccine uses a type of messenger RNA (mRNA) that instructs cells in the body to produce specific proteins, which can help fight cancer.